Tovaxin for multiple sclerosis

By Rivera Victor M  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 961-967

Informa Healthcare

Access to resources Recommend Favorite

A Novel Mitochondrial DNA Point Mutation in the tRNAIle Gene: Studies in a Patient Presenting with Chronic Progressive External Ophthalmoplegia and Multiple Sclerosis

By Taylor R.W.   Chinnery P.F.   Bates M.J.D.   Jackson M.J.   Johnson M.A.   Andrews R.M.   Turnbull D.M.  

Biochemical and Biophysical Research Communications, Vol. 243, Iss. 1, 1998-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Alemtuzumab and multiple sclerosis: therapeutic application

By Alireza Minagar   J Steven Alexander   Mohammad Ali Sahraian   Robert Zivadinov  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Current evaluation of alemtuzumab in multiple sclerosis

By Coyle Patricia Katherine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 127-135

Informa Healthcare

Access to resources Recommend Favorite

On the Catalytic Activity of Autoantibodies in Multiple Sclerosis

By Ponomarenko N. A.   Durova O. M.   Vorob'ev I. I.   Suchkov S. V.   Gabibov A. G.  

Doklady Biochemistry & Biophysics, Vol. 395, Iss. 1-6, 2004-03 ,pp. : 120-123

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite